According to Latest Research by Market IntelliX, the global market for Genetically Modified Drug should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.

China Genetically Modified Drug market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.

The United States Genetically Modified Drug market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.

In terms of type, Transgenic Animal segment holds a share about % in 2023 and will reach % in 2030; while in terms of application, Hospital has a share approximately % in 2023 and will grow at a CAGR % during 2023 and 2030.

The global key manufacturers of Genetically Modified Drug include LFB Biotechnologies SA, Pharming Group NV, Pfizer, Roche, Abbott Laboratories, Johnson & Johnson, Merck & Co., Amgen and F. Hoffmann-La Roche, etc. In 2023, the global top five players hold a share approximately % in terms of revenue.

Drugs made by genetically modified means are also called "biological drugs"

This report aims to provide a comprehensive study of the global market for Genetically Modified Drug. Report Highlights:

(1) Global Genetically Modified Drug market size (sales volume & revenue), history data from 2019-2024 and forecast data from 2024 to 2030.

(2) Global Genetically Modified Drug market competitive situation, sales, revenue, price and market share, from 2019 to 2024.

(3) China Genetically Modified Drug market competitive situation, sales, revenue, price and market share, from 2019 to 2024.

(4) Global Genetically Modified Drug segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.

(5) Global Genetically Modified Drug segment by type and by application and regional segment by type and by application.

(6) Global major production regions of Genetically Modified Drug, capacity, production and trends.

(7) Genetically Modified Drug industry supply chain, upstream, midstream and downstream analysis.

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa

Market segment by type, covers

Transgenic Animal

Transgenic Plant

Market segment by application, can be divided into

Hospital

Clinic

Market segment by players, this report covers

LFB Biotechnologies SA

Pharming Group NV

Pfizer

Roche

Abbott Laboratories

Johnson & Johnson

Merck & Co.

Amgen

F. Hoffmann-La Roche

Sanofi

Novartis

Eli Lilly

Takeda

Baxter

GlaxoSmithKline

1 Market Overview

1.1 Genetically Modified Drug Definition

1.2 Global Genetically Modified Drug Market Size and Forecast

1.2.1 By Revenue, Global Genetically Modified Drug Market Size, 2019-2030

1.2.2 By Sales Volume, Global Genetically Modified Drug Market Size, 2019-2030

1.2.3 Global Genetically Modified Drug Price Trend, 2019-2030

1.3 China Genetically Modified Drug Market Size and Forecast

1.3.1 By Revenue, China Genetically Modified Drug Market Size, 2019-2030

1.3.2 By Sales Volume, China Genetically Modified Drug Market Size, 2019-2030

1.3.3 China Genetically Modified Drug Price Trend, 2019-2030

1.4 China Percentage in Global Market

1.4.1 By Revenue, China Genetically Modified Drug Share in Global Market, 2019-2030

1.4.2 By Sales Volume, China Genetically Modified Drug Share in Global Market, 2019-2030

1.4.3 Genetically Modified Drug Market Size: China VS Global, 2019-2030

1.5 Genetically Modified Drug Market Dynamics

1.5.1 Genetically Modified Drug Market Drivers

1.5.2 Genetically Modified Drug Market Restraints

1.5.3 Genetically Modified Drug Industry Trends

1.5.4 Genetically Modified Drug Industry Policy

2 Global Competitive Landscape by Company

2.1 Global Genetically Modified Drug Revenue by Company, 2019-2024

2.2 Global Genetically Modified Drug Sales Volume by Company, 2019-2024

2.3 Global Genetically Modified Drug Price by Company, 2019-2024

2.4 Global Genetically Modified Drug Participants, Market Position (Tier 1, Tier 2 and Tier 3)

2.5 Global Genetically Modified Drug Concentration Ratio

2.6 Global Genetically Modified Drug Mergers & Acquisitions, Expansion Plans

2.7 Global Genetically Modified Drug Manufacturers Product Type

3 China Competitive Landscape by Company

3.1 China Genetically Modified Drug Revenue by Company, 2019-2024

3.2 China Genetically Modified Drug Sales Volume by Company, 2019-2024

3.3 China Genetically Modified Drug Genetically Modified Drug Participants, Market Position (Tier 1, Tier 2 and Tier 3)

3.4 China Genetically Modified Drug Market, Sales Percentage of Local Players VS Foreign Players (2019-2024)

3.5 Chinese Local Players, Genetically Modified Drug Domestic VS Export

3.6 China Market, Genetically Modified Drug Import & Export

3.6.1 China Market, Genetically Modified Drug Import & Export, 2019-2030

3.6.2 China Genetically Modified Drug Import & Export Trends

3.6.3 Main Sources of China Genetically Modified Drug Import

3.6.4 Export Destination of China Genetically Modified Drug

4 Genetically Modified Drug Production by Region

4.1 Global Genetically Modified Drug Capacity, Production and Capacity Utilization, 2019-2030

4.2 Global Geographic Distribution of Genetically Modified Drug Manufacturers

4.3 Global Major Manufacturers, Genetically Modified Drug Capacity Expansion and Future Plans

4.4 Global Genetically Modified Drug Capacity by Region

4.5 Global Genetically Modified Drug Production by Region

4.5.1 Global Genetically Modified Drug Production & Forecast by Region, 2019 VS 2024 VS 2030

4.5.2 Global Genetically Modified Drug Production by Region, 2019-2024

4.5.3 Global Genetically Modified Drug Production Market Share & Forecast by Region, 2019-2030

5 Industry Chain Analysis

5.1 Genetically Modified Drug Industry Chain

5.2 Genetically Modified Drug Upstream Analysis

5.2.1 Genetically Modified Drug Core Raw Materials

5.2.2 Main Manufacturers of Genetically Modified Drug Core Raw Materials

5.3 Midstream Analysis

5.4 Downstream Analysis

5.5 Genetically Modified Drug Production Mode

5.6 Genetically Modified Drug Procurement Model

5.7 Genetically Modified Drug Industry Sales Model and Sales Channels

5.7.1 Genetically Modified Drug Sales Model

5.7.2 Genetically Modified Drug Typical Distributors

6 Sights by Type

6.1 Genetically Modified Drug Classification

6.1.1 Transgenic Animal

6.1.2 Transgenic Plant

6.2 By Type, Global Genetically Modified Drug Market Size & CAGR, 2019 VS 2024 VS 2030

6.3 By Type, Global Genetically Modified Drug Revenue, 2019-2030

6.4 By Type, Global Genetically Modified Drug Sales Volume, 2019-2030

6.5 By Type, Global Genetically Modified Drug Price, 2019-2030

7 Sights by Application

7.1 Genetically Modified Drug Segment by Application

7.1.1 Hospital

7.1.2 Clinic

7.2 By Application, Global Genetically Modified Drug Market Size & CAGR, 2019 VS 2024 VS 2030

7.3 By Application, Global Genetically Modified Drug Revenue, 2019-2030

7.4 By Application, Global Genetically Modified Drug Sales Volume, 2019-2030

7.5 By Application, Global Genetically Modified Drug Price, 2019-2030

8 Sales Sights by Region

8.1 By Region, Global Genetically Modified Drug Market Size, 2019 VS 2024 VS 2030

8.2 By Region, Global Genetically Modified Drug Revenue, 2019-2030

8.3 By Region, Global Genetically Modified Drug Sales Volume, 2019-2030

8.4 North America

8.4.1 North America Genetically Modified Drug Market Size & Forecasts, 2019-2030

8.4.2 By Country, North America Genetically Modified Drug Market Size Market Share

8.5 Europe

8.5.1 Europe Genetically Modified Drug Market Size & Forecasts, 2019-2030

8.5.2 By Country, Europe Genetically Modified Drug Market Size Market Share

8.6 Asia Pacific

8.6.1 Asia Pacific Genetically Modified Drug Market Size & Forecasts, 2019-2030

8.6.2 By Country/Region, Asia Pacific Genetically Modified Drug Market Size Market Share

8.7 South America

8.7.1 South America Genetically Modified Drug Market Size & Forecasts, 2019-2030

8.7.2 By Country, South America Genetically Modified Drug Market Size Market Share

8.8 Middle East & Africa

9 Sales Sights by Country Level

9.1 By Country, Global Genetically Modified Drug Market Size & CAGR，2019 VS 2024 VS 2030

9.2 By Country, Global Genetically Modified Drug Revenue, 2019-2030

9.3 By Country, Global Genetically Modified Drug Sales Volume, 2019-2030

9.4 U.S.

9.4.1 U.S. Genetically Modified Drug Market Size, 2019-2030

9.4.2 By Company, U.S. Genetically Modified Drug Sales Volume Market Share, 2024

9.4.3 By Type, U.S. Genetically Modified Drug Market Size, Share, 2024 VS 2030

9.4.4 By Application, U.S. Genetically Modified Drug Market Size, Share, 2024 VS 2030

9.5 Europe

9.5.1 Europe Genetically Modified Drug Market Size, 2019-2030

9.5.2 By Company, Europe Genetically Modified Drug Sales Volume Market Share, 2024

9.5.3 By Type, Europe Genetically Modified Drug Market Size, Share, 2024 VS 2030

9.5.4 By Application, Europe Genetically Modified Drug Market Size, Share, 2024 VS 2030

9.6 China

9.6.1 China Genetically Modified Drug Market Size, 2019-2030

9.6.2 By Company, China Genetically Modified Drug Sales Volume Market Share, 2024

9.6.3 By Type, China Genetically Modified Drug Market Size, Share, 2024 VS 2030

9.6.4 By Application, China Genetically Modified Drug Market Size, Share, 2024 VS 2030

9.7 Japan

9.7.1 Japan Genetically Modified Drug Market Size, 2019-2030

9.7.2 By Company, Japan Genetically Modified Drug Sales Volume Market Share, 2024

9.7.3 By Type, Japan Genetically Modified Drug Market Size, Share, 2024 VS 2030

9.7.4 By Application, Japan Genetically Modified Drug Market Size, Share, 2024 VS 2030

9.8 South Korea

9.8.1 South Korea Genetically Modified Drug Market Size, 2019-2030

9.8.2 By Company, South Korea Genetically Modified Drug Sales Volume Market Share, 2024

9.8.3 By Type, South Korea Genetically Modified Drug Market Size, Share, 2024 VS 2030

9.8.4 By Application, South Korea Genetically Modified Drug Market Size, Share, 2024 VS 2030

9.9 Southeast Asia

9.9.1 Southeast Asia Genetically Modified Drug Market Size, 2019-2030

9.9.2 By Company, Southeast Asia Genetically Modified Drug Sales Volume Market Share, 2024

9.9.3 By Type, Southeast Asia Genetically Modified Drug Market Size, Share, 2024 VS 2030

9.9.4 By Application, Southeast Asia Genetically Modified Drug Market Size, Share, 2024 VS 2030

9.10 India

9.10.1 India Genetically Modified Drug Market Size, 2019-2030

9.10.2 By Company, India Genetically Modified Drug Sales Volume Market Share, 2024

9.10.3 By Type, India Genetically Modified Drug Market Size, Share, 2024 VS 2030

9.10.4 By Application, India Genetically Modified Drug Market Size, Share, 2024 VS 2030

9.11 Middle East & Asia

9.11.1 Middle East & Asia Genetically Modified Drug Market Size, 2019-2030

9.11.2 By Company, Middle East & Asia Genetically Modified Drug Sales Volume Market Share, 2024

9.11.3 By Type, Middle East & Asia Genetically Modified Drug Market Size, Share, 2024 VS 2030

9.11.4 By Application, Middle East & Asia Genetically Modified Drug Market Size, Share, 2024 VS 2030

10 Manufacturers Profile

10.1 LFB Biotechnologies SA

10.1.1 LFB Biotechnologies SA Company Information, Head Office, Market Area and Industry Position

10.1.2 LFB Biotechnologies SA Genetically Modified Drug Models, Specifications and Application

10.1.3 LFB Biotechnologies SA Genetically Modified Drug Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.1.4 LFB Biotechnologies SA Company Profile and Main Business

10.1.5 LFB Biotechnologies SA Recent Developments

10.2 Pharming Group NV

10.2.1 Pharming Group NV Company Information, Head Office, Market Area and Industry Position

10.2.2 Pharming Group NV Genetically Modified Drug Models, Specifications and Application

10.2.3 Pharming Group NV Genetically Modified Drug Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.2.4 Pharming Group NV Company Profile and Main Business

10.2.5 Pharming Group NV Recent Developments

10.3 Pfizer

10.3.1 Pfizer Company Information, Head Office, Market Area and Industry Position

10.3.2 Pfizer Genetically Modified Drug Models, Specifications and Application

10.3.3 Pfizer Genetically Modified Drug Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.3.4 Pfizer Company Profile and Main Business

10.3.5 Pfizer Recent Developments

10.4 Roche

10.4.1 Roche Company Information, Head Office, Market Area and Industry Position

10.4.2 Roche Genetically Modified Drug Models, Specifications and Application

10.4.3 Roche Genetically Modified Drug Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.4.4 Roche Company Profile and Main Business

10.4.5 Roche Recent Developments

10.5 Abbott Laboratories

10.5.1 Abbott Laboratories Company Information, Head Office, Market Area and Industry Position

10.5.2 Abbott Laboratories Genetically Modified Drug Models, Specifications and Application

10.5.3 Abbott Laboratories Genetically Modified Drug Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.5.4 Abbott Laboratories Company Profile and Main Business

10.5.5 Abbott Laboratories Recent Developments

10.6 Johnson & Johnson

10.6.1 Johnson & Johnson Company Information, Head Office, Market Area and Industry Position

10.6.2 Johnson & Johnson Genetically Modified Drug Models, Specifications and Application

10.6.3 Johnson & Johnson Genetically Modified Drug Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.6.4 Johnson & Johnson Company Profile and Main Business

10.6.5 Johnson & Johnson Recent Developments

10.7 Merck & Co.

10.7.1 Merck & Co. Company Information, Head Office, Market Area and Industry Position

10.7.2 Merck & Co. Genetically Modified Drug Models, Specifications and Application

10.7.3 Merck & Co. Genetically Modified Drug Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.7.4 Merck & Co. Company Profile and Main Business

10.7.5 Merck & Co. Recent Developments

10.8 Amgen

10.8.1 Amgen Company Information, Head Office, Market Area and Industry Position

10.8.2 Amgen Genetically Modified Drug Models, Specifications and Application

10.8.3 Amgen Genetically Modified Drug Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.8.4 Amgen Company Profile and Main Business

10.8.5 Amgen Recent Developments

10.9 F. Hoffmann-La Roche

10.9.1 F. Hoffmann-La Roche Company Information, Head Office, Market Area and Industry Position

10.9.2 F. Hoffmann-La Roche Genetically Modified Drug Models, Specifications and Application

10.9.3 F. Hoffmann-La Roche Genetically Modified Drug Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.9.4 F. Hoffmann-La Roche Company Profile and Main Business

10.9.5 F. Hoffmann-La Roche Recent Developments

10.10 Sanofi

10.10.1 Sanofi Company Information, Head Office, Market Area and Industry Position

10.10.2 Sanofi Genetically Modified Drug Models, Specifications and Application

10.10.3 Sanofi Genetically Modified Drug Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.10.4 Sanofi Company Profile and Main Business

10.10.5 Sanofi Recent Developments

10.11 Novartis

10.11.1 Novartis Company Information, Head Office, Market Area and Industry Position

10.11.2 Novartis Genetically Modified Drug Models, Specifications and Application

10.11.3 Novartis Genetically Modified Drug Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.11.4 Novartis Company Profile and Main Business

10.11.5 Novartis Recent Developments

10.12 Eli Lilly

10.12.1 Eli Lilly Company Information, Head Office, Market Area and Industry Position

10.12.2 Eli Lilly Genetically Modified Drug Models, Specifications and Application

10.12.3 Eli Lilly Genetically Modified Drug Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.12.4 Eli Lilly Company Profile and Main Business

10.12.5 Eli Lilly Recent Developments

10.13 Takeda

10.13.1 Takeda Company Information, Head Office, Market Area and Industry Position

10.13.2 Takeda Genetically Modified Drug Models, Specifications and Application

10.13.3 Takeda Genetically Modified Drug Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.13.4 Takeda Company Profile and Main Business

10.13.5 Takeda Recent Developments

10.14 Baxter

10.14.1 Baxter Company Information, Head Office, Market Area and Industry Position

10.14.2 Baxter Genetically Modified Drug Models, Specifications and Application

10.14.3 Baxter Genetically Modified Drug Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.14.4 Baxter Company Profile and Main Business

10.14.5 Baxter Recent Developments

10.15 GlaxoSmithKline

10.15.1 GlaxoSmithKline Company Information, Head Office, Market Area and Industry Position

10.15.2 GlaxoSmithKline Genetically Modified Drug Models, Specifications and Application

10.15.3 GlaxoSmithKline Genetically Modified Drug Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.15.4 GlaxoSmithKline Company Profile and Main Business

10.15.5 GlaxoSmithKline Recent Developments

11 Conclusion

12 Appendix

12.1 Research Methodology

12.2 Data Source

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Market Estimation Model

12.4 Disclaimer

Table 1. Genetically Modified Drug Market Size & CAGR: China VS Global, 2019-2030, US$ Million

Table 2. Genetically Modified Drug Market Restraints

Table 3. Genetically Modified Drug Market Trends

Table 4. Genetically Modified Drug Industry Policy

Table 5. Global Genetically Modified Drug Revenue by Company, 2019-2024, US$ million

Table 6. Global Genetically Modified Drug Revenue Market Share by Company, 2019-2024

Table 7. Global Genetically Modified Drug Sales Volume by Company, 2019-2024, (K Units)

Table 8. Global Genetically Modified Drug Sales Volume Market Share by Company, 2019-2024

Table 9. Global Genetically Modified Drug Price by Company, 2019-2024, (US$/Unit)

Table 10. Global Genetically Modified Drug Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 11. Global Genetically Modified Drug Mergers & Acquisitions, Expansion Plans

Table 12. Global Genetically Modified Drug Manufacturers Product Type

Table 13. China Genetically Modified Drug Revenue by Company, 2019-2024, US$ million

Table 14. China Genetically Modified Drug Revenue Market Share by Company, 2019-2024

Table 15. China Genetically Modified Drug Sales Volume by Company, 2019-2024, (K Units)

Table 16. China Genetically Modified Drug Sales Volume Market Share by Company, 2019-2024

Table 17. China Market, Genetically Modified Drug Production, Sales, Import and Export, 2019-2030, (K Units)

Table 18. China Genetically Modified Drug Import & Export Trends

Table 19. Main Sources of China Genetically Modified Drug Import

Table 20. Export Destination of China Genetically Modified Drug

Table 21. Global Headquarters and Manufacturing Base of Genetically Modified Drug Manufacturers

Table 22. Global Major Manufacturers, Genetically Modified Drug Capacity Expansion and Future Plans

Table 23. Global Genetically Modified Drug Production & Forecast by Region, 2019 VS 2024 VS 2030, (K Units)

Table 24. Global Genetically Modified Drug Production by Region, 2019-2024, (K Units)

Table 25. Global Genetically Modified Drug Production Forecast by Region, 2024-2030, (K Units)

Table 26. Global Key Players of Genetically Modified Drug Upstream (Raw Materials)

Table 27. Global Genetically Modified Drug Typical Customers

Table 28. Genetically Modified Drug Typical Distributors

Table 29. By Type, Global Genetically Modified Drug Revenue & CAGR, 2019 VS 2024 VS 2030, US$ Million

Table 30. By Application, Global Genetically Modified Drug Revenue & CAGR, 2019 VS 2024 VS 2030, US$ Million

Table 31. By Region, Global Genetically Modified Drug Market Size, 2019 VS 2024 VS 2030, US$ Million

Table 32. By Region, Global Genetically Modified Drug Revenue, 2019-2030, US$ Million

Table 33. By Region, Global Genetically Modified Drug Sales Volume, 2019-2030, (K Units)

Table 34. By Country, Global Genetically Modified Drug Revenue & CAGR，2019 VS 2024 VS 2030, US$ Million

Table 35. By Country, Global Genetically Modified Drug Revenue, 2019-2030, US$ Million

Table 36. By Country, Global Genetically Modified Drug Revenue Market Share, 2019-2030

Table 37. By Country, Global Genetically Modified Drug Sales Volume, 2019-2030, (K Units)

Table 38. By Country, Global Genetically Modified Drug Sales Volume Market Share, 2019-2030

Table 39. LFB Biotechnologies SA Company Information, Head Office, Market Area and Industry Position

Table 40. LFB Biotechnologies SA Genetically Modified Drug Models, Specifications and Application

Table 41. LFB Biotechnologies SA Genetically Modified Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 42. LFB Biotechnologies SA Company Profile and Main Business

Table 43. LFB Biotechnologies SA Recent Developments

Table 44. Pharming Group NV Company Information, Head Office, Market Area and Industry Position

Table 45. Pharming Group NV Genetically Modified Drug Models, Specifications and Application

Table 46. Pharming Group NV Genetically Modified Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 47. Pharming Group NV Company Profile and Main Business

Table 48. Pharming Group NV Recent Developments

Table 49. Pfizer Company Information, Head Office, Market Area and Industry Position

Table 50. Pfizer Genetically Modified Drug Models, Specifications and Application

Table 51. Pfizer Genetically Modified Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 52. Pfizer Company Profile and Main Business

Table 53. Pfizer Recent Developments

Table 54. Roche Company Information, Head Office, Market Area and Industry Position

Table 55. Roche Genetically Modified Drug Models, Specifications and Application

Table 56. Roche Genetically Modified Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 57. Roche Company Profile and Main Business

Table 58. Roche Recent Developments

Table 59. Abbott Laboratories Company Information, Head Office, Market Area and Industry Position

Table 60. Abbott Laboratories Genetically Modified Drug Models, Specifications and Application

Table 61. Abbott Laboratories Genetically Modified Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 62. Abbott Laboratories Company Profile and Main Business

Table 63. Abbott Laboratories Recent Developments

Table 64. Johnson & Johnson Company Information, Head Office, Market Area and Industry Position

Table 65. Johnson & Johnson Genetically Modified Drug Models, Specifications and Application

Table 66. Johnson & Johnson Genetically Modified Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 67. Johnson & Johnson Company Profile and Main Business

Table 68. Johnson & Johnson Recent Developments

Table 69. Merck & Co. Company Information, Head Office, Market Area and Industry Position

Table 70. Merck & Co. Genetically Modified Drug Models, Specifications and Application

Table 71. Merck & Co. Genetically Modified Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 72. Merck & Co. Company Profile and Main Business

Table 73. Merck & Co. Recent Developments

Table 74. Amgen Company Information, Head Office, Market Area and Industry Position

Table 75. Amgen Genetically Modified Drug Models, Specifications and Application

Table 76. Amgen Genetically Modified Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 77. Amgen Company Profile and Main Business

Table 78. Amgen Recent Developments

Table 79. F. Hoffmann-La Roche Company Information, Head Office, Market Area and Industry Position

Table 80. F. Hoffmann-La Roche Genetically Modified Drug Models, Specifications and Application

Table 81. F. Hoffmann-La Roche Genetically Modified Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 82. F. Hoffmann-La Roche Company Profile and Main Business

Table 83. F. Hoffmann-La Roche Recent Developments

Table 84. Sanofi Company Information, Head Office, Market Area and Industry Position

Table 85. Sanofi Genetically Modified Drug Models, Specifications and Application

Table 86. Sanofi Genetically Modified Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 87. Sanofi Company Profile and Main Business

Table 88. Sanofi Recent Developments

Table 89. Novartis Company Information, Head Office, Market Area and Industry Position

Table 90. Novartis Genetically Modified Drug Models, Specifications and Application

Table 91. Novartis Genetically Modified Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 92. Novartis Company Profile and Main Business

Table 93. Novartis Recent Developments

Table 94. Eli Lilly Company Information, Head Office, Market Area and Industry Position

Table 95. Eli Lilly Genetically Modified Drug Models, Specifications and Application

Table 96. Eli Lilly Genetically Modified Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 97. Eli Lilly Company Profile and Main Business

Table 98. Eli Lilly Recent Developments

Table 99. Takeda Company Information, Head Office, Market Area and Industry Position

Table 100. Takeda Genetically Modified Drug Models, Specifications and Application

Table 101. Takeda Genetically Modified Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 102. Takeda Company Profile and Main Business

Table 103. Takeda Recent Developments

Table 104. Baxter Company Information, Head Office, Market Area and Industry Position

Table 105. Baxter Genetically Modified Drug Models, Specifications and Application

Table 106. Baxter Genetically Modified Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 107. Baxter Company Profile and Main Business

Table 108. Baxter Recent Developments

Table 109. GlaxoSmithKline Company Information, Head Office, Market Area and Industry Position

Table 110. GlaxoSmithKline Genetically Modified Drug Models, Specifications and Application

Table 111. GlaxoSmithKline Genetically Modified Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 112. GlaxoSmithKline Company Profile and Main Business

Table 113. GlaxoSmithKline Recent Developments

List of Figure

Figure 1. Genetically Modified Drug Picture

Figure 2. By Revenue, Global Genetically Modified Drug Market Size and Forecast, 2019-2030, US$ Million

Figure 3. By Sales Volume, Global Genetically Modified Drug Market Size and Forecast, 2019-2030, (K Units)

Figure 4. Global Genetically Modified Drug Price Trend, 2019-2030, (US$/Unit)

Figure 5. By Revenue, China Genetically Modified Drug Market Size and Forecast, 2019-2030, US$ million

Figure 6. By Sales Volume, China Genetically Modified Drug Market Size and Forecast, 2019-2030, (K Units)

Figure 7. China Genetically Modified Drug Price Trend, 2019-2030 (US$/Unit)

Figure 8. By Revenue, China Genetically Modified Drug Share of Global Market, 2019-2030

Figure 9. By Sales Volume, China Genetically Modified Drug Share of Global Market, 2019-2030

Figure 10. Global Genetically Modified Drug Key Participants, Market Share, 2021 VS 2024 VS 2024

Figure 11. Global Genetically Modified Drug Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2024

Figure 12. China Genetically Modified Drug Key Participants, Market Share, 2021 VS 2024 VS 2024

Figure 13. China Genetically Modified Drug Key Participants, Market Share, 2021 VS 2024 VS 2024

Figure 14. China Genetically Modified Drug Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2019-2024

Figure 15. Chinese Local Players, Proportion of Genetically Modified Drug Domestic VS Export, 2024

Figure 16. Global Genetically Modified Drug Capacity, Production and Capacity Utilization, 2019-2030

Figure 17. Global Genetically Modified Drug Capacity Market Share by Region, 2024 VS 2030

Figure 18. Global Genetically Modified Drug Production Market Share & Forecast by Region, 2019-2030

Figure 19. Genetically Modified Drug Industry Chain

Figure 20. Genetically Modified Drug Procurement Model

Figure 21. Genetically Modified Drug Sales Model

Figure 22. Genetically Modified Drug Sales Channels, Direct Sales and Distribution

Figure 23. Transgenic Animal

Figure 24. Transgenic Plant

Figure 25. By Type, Global Genetically Modified Drug Revenue, 2019-2030, US$ Million

Figure 26. By Type, Global Genetically Modified Drug Revenue Market Share, 2019-2030

Figure 27. By Type, Global Genetically Modified Drug Sales Volume, 2019-2030, (K Units)

Figure 28. By Type, Global Genetically Modified Drug Sales Volume Market Share, 2019-2030

Figure 29. By Type, Global Genetically Modified Drug Price, 2019-2030, (US$/Unit)

Figure 30. Hospital

Figure 31. Clinic

Figure 32. By Application, Global Genetically Modified Drug Revenue, 2019-2030, US$ Million

Figure 33. By Application, Global Genetically Modified Drug Revenue Market Share, 2019-2030

Figure 34. By Application, Global Genetically Modified Drug Sales Volume, 2019-2030, (K Units)

Figure 35. By Application, Global Genetically Modified Drug Sales Volume Market Share, 2019-2030

Figure 36. By Application, Global Genetically Modified Drug Price, 2019-2030, (US$/Unit)

Figure 37. By Region, Global Genetically Modified Drug Revenue Market Share, 2019-2030

Figure 38. By Region, Global Genetically Modified Drug Sales Volume Market Share, 2019-2030

Figure 39. North America Genetically Modified Drug Revenue & Forecasts, 2019-2030, US$ Million

Figure 40. By Country, North America Genetically Modified Drug Revenue Market Share, 2024

Figure 41. Europe Genetically Modified Drug Revenue & Forecasts, 2019-2030, US$ Million

Figure 42. By Country, Europe Genetically Modified Drug Revenue Market Share, 2024

Figure 43. Asia Pacific Genetically Modified Drug Revenue & Forecasts, 2019-2030, US$ Million

Figure 44. By Country/Region, Asia Pacific Genetically Modified Drug Revenue Market Share, 2024

Figure 45. South America Genetically Modified Drug Revenue & Forecasts, 2019-2030, US$ Million

Figure 46. By Country, South America Genetically Modified Drug Revenue Market Share, 2024

Figure 47. Middle East & Africa Genetically Modified Drug Revenue & Forecasts, 2019-2030, US$ Million

Figure 48. U.S. Genetically Modified Drug Sales Volume, 2019-2030, (K Units)

Figure 49. By Company, U.S. Genetically Modified Drug Market Share, 2024

Figure 50. By Type, U.S. Genetically Modified Drug Sales Volume Market Share, 2024 VS 2030

Figure 51. By Application, U.S. Genetically Modified Drug Sales Volume Market Share, 2024 VS 2030

Figure 52. Europe Genetically Modified Drug Sales Volume, 2019-2030, (K Units)

Figure 53. By Company, Europe Genetically Modified Drug Market Share, 2024

Figure 54. By Type, Europe Genetically Modified Drug Sales Volume Market Share, 2024 VS 2030

Figure 55. By Application, Europe Genetically Modified Drug Sales Volume Market Share, 2024 VS 2030

Figure 56. China Genetically Modified Drug Sales Volume, 2019-2030, (K Units)

Figure 57. By Company, China Genetically Modified Drug Market Share, 2024

Figure 58. By Type, China Genetically Modified Drug Sales Volume Market Share, 2024 VS 2030

Figure 59. By Application, China Genetically Modified Drug Sales Volume Market Share, 2024 VS 2030

Figure 60. Japan Genetically Modified Drug Sales Volume, 2019-2030, (K Units)

Figure 61. By Company, Japan Genetically Modified Drug Market Share, 2024

Figure 62. By Type, Japan Genetically Modified Drug Sales Volume Market Share, 2024 VS 2030

Figure 63. By Application, Japan Genetically Modified Drug Sales Volume Market Share, 2024 VS 2030

Figure 64. South Korea Genetically Modified Drug Sales Volume, 2019-2030, (K Units)

Figure 65. By Company, South Korea Genetically Modified Drug Market Share, 2024

Figure 66. By Type, South Korea Genetically Modified Drug Sales Volume Market Share, 2024 VS 2030

Figure 67. By Application, South Korea Genetically Modified Drug Sales Volume Market Share, 2024 VS 2030

Figure 68. Southeast Asia Genetically Modified Drug Sales Volume, 2019-2030, (K Units)

Figure 69. By Company, Southeast Asia Genetically Modified Drug Market Share, 2024

Figure 70. By Type, Southeast Asia Genetically Modified Drug Sales Volume Market Share, 2024 VS 2030

Figure 71. By Application, Southeast Asia Genetically Modified Drug Sales Volume Market Share, 2024 VS 2030

Figure 72. India Genetically Modified Drug Sales Volume, 2019-2030, (K Units)

Figure 73. By Company, India Genetically Modified Drug Market Share, 2024

Figure 74. By Type, India Genetically Modified Drug Sales Volume Market Share, 2024 VS 2030

Figure 75. By Application, India Genetically Modified Drug Sales Volume Market Share, 2024 VS 2030

Figure 76. Middle East & Asia Genetically Modified Drug Sales Volume, 2019-2030, (K Units)

Figure 77. By Company, Middle East & Asia Genetically Modified Drug Market Share, 2024

Figure 78. By Type, Middle East & Asia Genetically Modified Drug Sales Volume Market Share, 2024 VS 2030

Figure 79. By Application, Middle East & Asia Genetically Modified Drug Sales Volume Market Share, 2024 VS 2030

Figure 80. Research Methodology

Figure 81. Breakdown of Primary Interviews

Figure 82. Bottom-up Approaches

Figure 83. Top-down Approaches

Methodology/Research Approach

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

Research Programs/Design

Historical Data (2015-2019)	Industry Trends Competitive Landscape By Company Expansion Mergers and Acquisitions Market Segment by Type by Application By Regions/ Geography	Value Status and Outlook Value for Major Players Market Share Growth Rate Present Situation Analysis Value Market Share Growth Rate Present Situation Analysis
Influencing Factors	Market Environment Government Policy Technological Changes Market Risks	Market Drivers Growing Demand of Downstream Reduction in Cost
Market Forecast (2021-2026)	Overall Size by Type by Application By Regions/Geography	Key Data (Value) Market Share Growth Rate CAGR (2021-2026)

Market Size Estimation

Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).

The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.

Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.

All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report

The following figure shows an illustrative representation of the overall market size estimation process used for this study.

Market Breakdown and Data Triangulation

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.

Data Source

Secondary Sources

Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.

Market Size	Segmental value Geographic Penetration Product Adoption Rate for Different market	Journals, Websites, and Press Releases Annual Reports and SEC Filings Company Websites and Press Releases Public and Paid Databases Market Intellix Data Repository
Market Position of Top Company	Product Financials Geographic value Mix Total Company value Business/Segmental value Mix
Qualitative Analysis	Influence Factors Market Potential Market Risks and Opportunities Industry Trends Geographical Features Government Policies	Company Websites and Press Releases Public and Paid Databases Annual Reports Industry Associations Market Intellix Data Repository

Primary Sources

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.

Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.

Key Executives Interviewed

Key Data Information from Primary Sources

Primary Sources	Parameters	Key Data
Market Segments(by Application, by Type)	Value by Type Status and Forecast Value by Application Value by Regions, Status and Forecast (2021-2026)	Value Market Share by Type Value Growth Rate by Type Value by Application Percentage and Growth Rate by Application Value Growth Rate and Market Share by Regions Market Size Status and Forecast (2021-2026)
Total Market	Overall Size, Status and Forecast	Market Size Status and Forecast (2021-2026)